Kubra Neslihan Kurt Oktay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kubra Neslihan Kurt Oktay has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Duygu Geler Külcü
Department of Physical Medicine and Rehabilitation University of Health Sciences, Haydarpaşa Numune Training and Research Hospital Istanbul Turkey
4 shared publications - Ahmet Sumen
BAM Clinic of Physical Medicine and Rehabilitation, Istanbul, Turkey
3 shared publications - Feyza Unlu Ozkan
Department of Physical Medicine and Rehabilitation, Fatih Sultan Mehmet Training and Research Hospital, University of Health Sciences, Istanbul, Turkiye
3 shared publications - İlknur Aktaş
Department of Physical Medicine and Rehabilitation, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Türkiye
3 shared publications - Arzu Atici
Department of Physical Medicine and Rehabilitation, University of Health Science, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey
2 shared publications Ebru Yilmaz
Department of Physical Medicine and Rehabilitation, Antalya Medstar Hospital, Antalya, Turkey
2 shared publications
Latest Publications
- 4 August 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (8) , e70805
Case Report: Leflunomide‐Induced Cutaneous Eruption in a Patient With Probable Chemotherapy‐Associated Inflammatory Polyarthritis
- 4 August 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (8) , e70805
Case Report: Leflunomide‐Induced Cutaneous Eruption in a Patient With Probable Chemotherapy‐Associated Inflammatory Polyarthritis
- 8 May 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (10) , 2645-2646
Oromandibular Dystonia Associated with Long‐Term Adalimumab Therapy
- 8 May 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (10) , 2645-2646
Oromandibular Dystonia Associated with Long‐Term Adalimumab Therapy
- Open Access
Kinesiophobia and alexithymia in knee osteoarthritis: association with radiological severity
Background: Pain and disability in knee osteoarthritis (KO) are influenced by both structural and psychosocial factors. However, the roles of kinesiophobia and alexithymia in KO remain poorly understood. Objective: To investigate the relationships among kinesiophobia, alexithymia, and radiographic severity in patients with KO. Methods: In this cross-sectional study, 109 adults with clinically and radiographically confirmed KO were recruited from two tertiary care centers. Demographic and clinical data were also collected. Pain intensity at rest and during movement was measured using the Visual Analog Scale (VAS), kinesiophobia with the Tampa Scale of Kinesiophobia (TSK), and alexithymia with the Toronto Alexithymia Scale (TAS). Radiographic severity was graded according to the Kellgren–Lawrence (KL) classification. Correlation and logistic regression analyses were conducted. Results: Kinesiophobia increased significantly with higher KL grade (r = 0.341, p < 0.001), whereas total alexithymia scores were not directly associated with radiographic severity. However, scores on the TAS subscale for difficulty identifying feelings (TAS-DIF) increased with higher KL stages (r = 0.300, p = 0.002). Kinesiophobia was further related to greater movement-evoked pain (r = 0.206, p = 0.035), higher body mass index (r = 0.317, p < 0.001), and lower education levels (r = −0.300, p = 0.002), while alexithymia was associated with movement-related evoked pain (r = 0.247, p = 0.011), lower educational attainment (r = −0.224, p = 0.021), comorbidity (r = −0.279, p = 0.004), and female sex (r = −0.201, p = 0.039). No variable independently predicted alexithymia in logistic regression analysis. Conclusion: Higher radiological severity and greater movement-evoked pain are linked to increased fear of movement, whereas alexithymia appears less dependent on structural degeneration and more related to individual psychological factors. These results emphasize the interconnection between physical and psychosocial components in KOA and support a multidisciplinary, biopsychosocial approach that incorporates emotional assessment and fear-reduction strategies into routine management.
Open AccessKinesiophobia and alexithymia in knee osteoarthritis: association with radiological severity
Background: Pain and disability in knee osteoarthritis (KO) are influenced by both structural and psychosocial factors. However, the roles of kinesiophobia and alexithymia in KO remain poorly understood. Objective: To investigate the relationships among kinesiophobia, alexithymia, and radiographic severity in patients with KO. Methods: In this cross-sectional study, 109 adults with clinically and radiographically confirmed KO were recruited from two tertiary care centers. Demographic and clinical data were also collected. Pain intensity at rest and during movement was measured using the Visual Analog Scale (VAS), kinesiophobia with the Tampa Scale of Kinesiophobia (TSK), and alexithymia with the Toronto Alexithymia Scale (TAS). Radiographic severity was graded according to the Kellgren–Lawrence (KL) classification. Correlation and logistic regression analyses were conducted. Results: Kinesiophobia increased significantly with higher KL grade (r = 0.341, p < 0.001), whereas total alexithymia scores were not directly associated with radiographic severity. However, scores on the TAS subscale for difficulty identifying feelings (TAS-DIF) increased with higher KL stages (r = 0.300, p = 0.002). Kinesiophobia was further related to greater movement-evoked pain (r = 0.206, p = 0.035), higher body mass index (r = 0.317, p < 0.001), and lower education levels (r = −0.300, p = 0.002), while alexithymia was associated with movement-related evoked pain (r = 0.247, p = 0.011), lower educational attainment (r = −0.224, p = 0.021), comorbidity (r = −0.279, p = 0.004), and female sex (r = −0.201, p = 0.039). No variable independently predicted alexithymia in logistic regression analysis. Conclusion: Higher radiological severity and greater movement-evoked pain are linked to increased fear of movement, whereas alexithymia appears less dependent on structural degeneration and more related to individual psychological factors. These results emphasize the interconnection between physical and psychosocial components in KOA and support a multidisciplinary, biopsychosocial approach that incorporates emotional assessment and fear-reduction strategies into routine management.
- 18 January 2026
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 202, 112544
Association between disability and alexithymia in lumbar disc herniation: A cross-sectional study
- 18 January 2026
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 202, 112544
Association between disability and alexithymia in lumbar disc herniation: A cross-sectional study
- 28 November 2025
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 105 (4) , e60-e62
Femoral Neck Bone Marrow Edema During Isotretinoin Therapy
Isotretinoin is a widely prescribed retinoid for severe acne, with musculoskeletal adverse effects such—particularly sacroiliitis—well documented in the literature. However, isolated femoral neck bone marrow edema has not previously been reported. We describe a 27-yr-old female physical medicine and rehabilitation resident who developed acute right hip pain while receiving isotretinoin therapy. Pelvic radiography and sacroiliac magnetic resonance imaging, obtained independently by the patient, were normal, but as symptoms progressed, she was examined by a physiatrist, and careful clinical assessment with accurate localization of pain prompted a dedicated hip magnetic resonance imaging, which revealed isolated femoral neck bone marrow edema. Laboratory evaluation excluded infection, inflammatory arthritis, and metabolic bone disease. Isotretinoin was discontinued, and the patient was treated conservatively with weight-bearing restriction, vitamin D and calcium supplementation, and analgesics, leading to complete clinical and radiologic resolution within 3 mos. This case represents the first report of isolated femoral neck bone marrow edema linked to isotretinoin therapy and underscores the importance of early recognition, as timely diagnosis through precise clinical assessment and targeted imaging enables unloading strategies that can prevent progression to stress fracture and ensure favorable outcomes in isotretinoin-treated patients presenting with hip pain.
- 28 November 2025
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 105 (4) , e60-e62
Femoral Neck Bone Marrow Edema During Isotretinoin Therapy
Isotretinoin is a widely prescribed retinoid for severe acne, with musculoskeletal adverse effects such—particularly sacroiliitis—well documented in the literature. However, isolated femoral neck bone marrow edema has not previously been reported. We describe a 27-yr-old female physical medicine and rehabilitation resident who developed acute right hip pain while receiving isotretinoin therapy. Pelvic radiography and sacroiliac magnetic resonance imaging, obtained independently by the patient, were normal, but as symptoms progressed, she was examined by a physiatrist, and careful clinical assessment with accurate localization of pain prompted a dedicated hip magnetic resonance imaging, which revealed isolated femoral neck bone marrow edema. Laboratory evaluation excluded infection, inflammatory arthritis, and metabolic bone disease. Isotretinoin was discontinued, and the patient was treated conservatively with weight-bearing restriction, vitamin D and calcium supplementation, and analgesics, leading to complete clinical and radiologic resolution within 3 mos. This case represents the first report of isolated femoral neck bone marrow edema linked to isotretinoin therapy and underscores the importance of early recognition, as timely diagnosis through precise clinical assessment and targeted imaging enables unloading strategies that can prevent progression to stress fracture and ensure favorable outcomes in isotretinoin-treated patients presenting with hip pain.
- Open Access
- 12 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (37) , e44387
Neurogenic pectoralis minor syndrome in the differential diagnosis of neck pain: A case series with diagnostic ultrasound-guided pectoralis minor muscle block
Rationale: Neurogenic pectoralis minor syndrome (NPMiS) is an underdiagnosed cause of persistent neck, shoulder, and upper extremity pain. It can mimic cervical radiculopathy or other musculoskeletal disorders, often resulting in misdiagnosis and ineffective treatment. This case series presents 5 patients with NPMiS who achieved symptomatic relief through diagnostic ultrasound-guided pectoralis minor muscle (PMiM) block followed by targeted rehabilitation. Patient concerns: All patients presented with persistent neck pain often radiating to the scapula or anterior chest wall, along with paresthesia and impaired sleep quality. Prior treatments, including non-steroidal anti-inflammatory drugs, muscle relaxants, and physical therapy, were ineffective. One patient was referred for spine surgery before alternative evaluation. Diagnoses: The diagnosis of NPMiS was based on detailed clinical history, positive physical exam findings (e.g., Roos test, focal PMiM tenderness), and exclusion of cervical radiculopathy and peripheral neuropathies via imaging and electrophysiological studies. Confirmatory diagnosis was established with significant symptom relief following ultrasound-guided PMiM block. Interventions: Patients received diagnostic ultrasound-guided injection of 1% lidocaine into the PMiM. This was followed by an individualized rehabilitation program including posture correction, ergonomic adjustments, and physical therapy focused on pectoral muscle stretching and shoulder stabilization. Outcomes: Patients experienced rapid pain reduction, improved function, reduced medication use, and better sleep. Sustained symptom relief was achieved through adherence to rehabilitation. Lessons: NPMiS should be considered in the differential diagnosis of chronic, non-dermatomal neck and upper extremity pain, particularly when standard treatments fail. Ultrasound-guided PMiM block is a valuable tool both for confirming diagnosis and initiating effective, personalized therapy strategies.
- 12 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (37) , e44387
Open AccessNeurogenic pectoralis minor syndrome in the differential diagnosis of neck pain: A case series with diagnostic ultrasound-guided pectoralis minor muscle block
Rationale: Neurogenic pectoralis minor syndrome (NPMiS) is an underdiagnosed cause of persistent neck, shoulder, and upper extremity pain. It can mimic cervical radiculopathy or other musculoskeletal disorders, often resulting in misdiagnosis and ineffective treatment. This case series presents 5 patients with NPMiS who achieved symptomatic relief through diagnostic ultrasound-guided pectoralis minor muscle (PMiM) block followed by targeted rehabilitation. Patient concerns: All patients presented with persistent neck pain often radiating to the scapula or anterior chest wall, along with paresthesia and impaired sleep quality. Prior treatments, including non-steroidal anti-inflammatory drugs, muscle relaxants, and physical therapy, were ineffective. One patient was referred for spine surgery before alternative evaluation. Diagnoses: The diagnosis of NPMiS was based on detailed clinical history, positive physical exam findings (e.g., Roos test, focal PMiM tenderness), and exclusion of cervical radiculopathy and peripheral neuropathies via imaging and electrophysiological studies. Confirmatory diagnosis was established with significant symptom relief following ultrasound-guided PMiM block. Interventions: Patients received diagnostic ultrasound-guided injection of 1% lidocaine into the PMiM. This was followed by an individualized rehabilitation program including posture correction, ergonomic adjustments, and physical therapy focused on pectoral muscle stretching and shoulder stabilization. Outcomes: Patients experienced rapid pain reduction, improved function, reduced medication use, and better sleep. Sustained symptom relief was achieved through adherence to rehabilitation. Lessons: NPMiS should be considered in the differential diagnosis of chronic, non-dermatomal neck and upper extremity pain, particularly when standard treatments fail. Ultrasound-guided PMiM block is a valuable tool both for confirming diagnosis and initiating effective, personalized therapy strategies.
- Open Access
- 30 July 2025
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 7 (3) , 100656
Ultrasound findings in patients with knee osteoarthritis: Relationships with clinical characteristics, radiographic findings and generalized osteoarthritis
- 30 July 2025
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 7 (3) , 100656
Open AccessUltrasound findings in patients with knee osteoarthritis: Relationships with clinical characteristics, radiographic findings and generalized osteoarthritis
- 18 March 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (5) , 2033-2035
Answer to the letter to the editor of J. Yao, et al. concerning “magnetic resonance imaging ultrasonography fusion-guided transforaminal epidural steroid injection: a retrospective cohort” by Ahmet Sumen, et al. (Eur spine J [2025]: doi.org/10.1007/s00586-025-08705-3)
- 18 March 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (5) , 2033-2035
Answer to the letter to the editor of J. Yao, et al. concerning “magnetic resonance imaging ultrasonography fusion-guided transforaminal epidural steroid injection: a retrospective cohort” by Ahmet Sumen, et al. (Eur spine J [2025]: doi.org/10.1007/s00586-025-08705-3)
- 6 February 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (4) , 1552-1561
Magnetic resonance imaging ultrasonography fusion-guided transforaminal epidural steroid injection: a retrospective cohort
Purpose This study aimed to evaluate the applicability and technical feasibility of magnetic resonance imaging (MRI) and ultrasonography (US) fusion-guided transforaminal epidural steroid injection (TFESI) in patients with lumbar disc herniation (LDH) leading to radiculopathy, who are unresponsive to conservative treatment. Methods This retrospective study included 21 patients aged 18–65 years who underwent MRI-US fusion-guided TFESI for LDH-induced radiculopathy. Patient data, including demographic characteristics, body mass index (BMI), fluoroscopy duration, radiation dose, and procedure success, were analyzed. Success was defined by the contrast-spread pattern during the procedure. Statistical analyses were performed to identify factors predicting procedural success. Results The MRI-US fusion-guided TFESI procedure was successful in 81% of patients. Successful outcomes were significantly associated with younger age (≤ 56 years, p < 0.001), lower BMI (≤ 28 kg/m², p < 0.001), shorter fluoroscopy duration (> 4.9 s, p < 0.001), and lower radiation dose (> 3.7 mGy, p < 0.001). A positive correlation was observed between age and radiation dose (p = 0.030), as well as between BMI and radiation dose (p = 0.049). Conclusion MRI-US fusion-guided TFESI is a feasible and safe technique with a high success rate and low radiation exposure in patients with LDH-induced radiculopathy. Younger age, lower BMI, shorter fluoroscopy duration, and lower radiation dose are significant predictors of procedural success. This technique may enhance spatial orientation during the procedure, potentially improving outcomes particularly in younger patients with lower BMI.
- 6 February 2025
- Published by Springer Nature in European Spine Journal
- Vol. 34 (4) , 1552-1561
Magnetic resonance imaging ultrasonography fusion-guided transforaminal epidural steroid injection: a retrospective cohort
Purpose This study aimed to evaluate the applicability and technical feasibility of magnetic resonance imaging (MRI) and ultrasonography (US) fusion-guided transforaminal epidural steroid injection (TFESI) in patients with lumbar disc herniation (LDH) leading to radiculopathy, who are unresponsive to conservative treatment. Methods This retrospective study included 21 patients aged 18–65 years who underwent MRI-US fusion-guided TFESI for LDH-induced radiculopathy. Patient data, including demographic characteristics, body mass index (BMI), fluoroscopy duration, radiation dose, and procedure success, were analyzed. Success was defined by the contrast-spread pattern during the procedure. Statistical analyses were performed to identify factors predicting procedural success. Results The MRI-US fusion-guided TFESI procedure was successful in 81% of patients. Successful outcomes were significantly associated with younger age (≤ 56 years, p < 0.001), lower BMI (≤ 28 kg/m², p < 0.001), shorter fluoroscopy duration (> 4.9 s, p < 0.001), and lower radiation dose (> 3.7 mGy, p < 0.001). A positive correlation was observed between age and radiation dose (p = 0.030), as well as between BMI and radiation dose (p = 0.049). Conclusion MRI-US fusion-guided TFESI is a feasible and safe technique with a high success rate and low radiation exposure in patients with LDH-induced radiculopathy. Younger age, lower BMI, shorter fluoroscopy duration, and lower radiation dose are significant predictors of procedural success. This technique may enhance spatial orientation during the procedure, potentially improving outcomes particularly in younger patients with lower BMI.
- Open Access
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (3) , 377-383
Comparison of the effects of duloxetine and pregabalin on pain and associated factors in patients with knee osteoarthritis
This study aimed to investigate the effects of duloxetine and pregabalin primarily on pain and functional status in patients with knee osteoarthritis and secondarily on quality of life, depression, anxiety, and sleep disturbance. A total of 66 patients with knee osteoarthritis were randomized to use duloxetine or pregabalin. Patients were evaluated by Visual Analog Scale, Neuropathic Pain Diagnostic Questionnaire, Western Ontario and McMaster University Osteoarthritis Index, Short Form-36, Beck Depression Inventory, Beck Anxiety Inventory, and Pittsburg Sleep Quality Index before the treatment and after 4 and 12 weeks of treatment. Improvements occurred in Visual Analog Scale, Neuropathic Pain Diagnostic Questionnaire, Western Ontario and McMaster University Osteoarthritis Index, Short Form-36 (with an exception of the mental health subgroup scores in duloxetine-treated group), Beck Depression Inventory, and Beck Anxiety Inventory scores in both groups from 4 weeks after baseline. Pittsburg Sleep Quality Index total scores and SF-36 mental health subgroup scores started to improve on the 4th and 12th weeks in pregabalin- and duloxetine-treated groups, respectively. Osteoarthritis pain, a complex outcome with nociceptive and neuropathic components, leads to central sensitization in a chronic phase. Using centrally acting drugs in the control of pain and associated symptoms would increase the probability of treatment success.
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (3) , 377-383
Open AccessComparison of the effects of duloxetine and pregabalin on pain and associated factors in patients with knee osteoarthritis
This study aimed to investigate the effects of duloxetine and pregabalin primarily on pain and functional status in patients with knee osteoarthritis and secondarily on quality of life, depression, anxiety, and sleep disturbance. A total of 66 patients with knee osteoarthritis were randomized to use duloxetine or pregabalin. Patients were evaluated by Visual Analog Scale, Neuropathic Pain Diagnostic Questionnaire, Western Ontario and McMaster University Osteoarthritis Index, Short Form-36, Beck Depression Inventory, Beck Anxiety Inventory, and Pittsburg Sleep Quality Index before the treatment and after 4 and 12 weeks of treatment. Improvements occurred in Visual Analog Scale, Neuropathic Pain Diagnostic Questionnaire, Western Ontario and McMaster University Osteoarthritis Index, Short Form-36 (with an exception of the mental health subgroup scores in duloxetine-treated group), Beck Depression Inventory, and Beck Anxiety Inventory scores in both groups from 4 weeks after baseline. Pittsburg Sleep Quality Index total scores and SF-36 mental health subgroup scores started to improve on the 4th and 12th weeks in pregabalin- and duloxetine-treated groups, respectively. Osteoarthritis pain, a complex outcome with nociceptive and neuropathic components, leads to central sensitization in a chronic phase. Using centrally acting drugs in the control of pain and associated symptoms would increase the probability of treatment success.